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Bruno et al. (2017) presented an interesting study 
on the genetic variants of β-casofensin, a bioactive 
peptide corresponding to bovine β-casein A2 f94–123, 
with promising effects on intestinal health (Plaisancié 
et al., 2013, 2015). However, we have to underline that 
A1 variant differs from A2 by only a single amino acid 
(Pro67 in A
2 vs. His67 in A
1). This substitution is re-
sponsible for the scientific and commercial debate on 
“A2 milk,” which involves different genetic variants 
(Caroli et al., 2009).
Thus, no difference exists between the A2 and A1 
variants within the β-casofensin sequence. The nomen-
clature on milk protein variants is precise and updated, 
based on a wide literature on the subject. Reviews 
are available on milk protein variant nomenclature, 
sequences, and effects (e.g., Formaggioni et al., 1999; 
Farrell et al., 2004; Caroli et al., 2009). Bruno et al. 
(2017) refer to a substitution Glu117 versus Gln117 oc-
curring in variants A1 and G. This substitution was 
described by Lebrun et al. (1995) in a proteomic study 
carried out on commercial casein but was not referred 
to as a genetic variant. Senocq et al. (2002) reported 
a substitution from Glu to Gln within the f114–169 
sequence. This variant, which also differs from A2 by 2 
residues at positions 72 and 93, was named H2 (Farrell 
et al., 2004).
Within β-casofensin, genetic differences in A3 (resi-
due 106) and B (residue 122) variants were properly 
accounted for by Bruno et al. (2017). Another inter-
esting variant to be investigated is β-casein I, which 
differs from A2 by a Met93 to Leu93 substitution (Caroli 
et al., 2009). An intriguing question could be whether 
the cleavage site that results in β-casofensin could be 
affected by this exchange.
In conclusion, the genetic polymorphism of bovine 
β-casein remains an open matter. Further efforts occur 
to understand and exploit it better without forgetting 
the existing nomenclature.
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